Ergun Y Uc1, Kevin C Doerschug2, Vincent Magnotta2, Jeffrey D Dawson2, Teri R Thomsen2, Joel N Kline2, Matthew Rizzo2, Sara R Newman2, Sonya Mehta2, Thomas J Grabowski2, Joel Bruss2, Derek R Blanchette2, Steven W Anderson2, Michelle W Voss2, Arthur F Kramer2, Warren G Darling2. 1. From the Departments of Neurology (E.Y.U., T.R.T., M.R., S.R.N., J.B., S.W.A.), Internal Medicine (K.C.D., J.N.K.), Radiology (V.M.), Biostatistics (J.D.D., D.R.B.), Psychology (M.W.V.), and Health and Human Physiology (W.G.D.), University of Iowa, Iowa City; Neurology Service (E.Y.U., T.R.T., S.R.N.), Veterans Affairs Medical Center, Iowa City, IA; Department of Neurology (S.M., T.J.G.), University of Washington, Seattle; and Department of Psychology (A.F.K.), Beckman Institute, University of Illinois, Urbana-Champaign. ergun-uc@uiowa.edu. 2. From the Departments of Neurology (E.Y.U., T.R.T., M.R., S.R.N., J.B., S.W.A.), Internal Medicine (K.C.D., J.N.K.), Radiology (V.M.), Biostatistics (J.D.D., D.R.B.), Psychology (M.W.V.), and Health and Human Physiology (W.G.D.), University of Iowa, Iowa City; Neurology Service (E.Y.U., T.R.T., S.R.N.), Veterans Affairs Medical Center, Iowa City, IA; Department of Neurology (S.M., T.J.G.), University of Washington, Seattle; and Department of Psychology (A.F.K.), Beckman Institute, University of Illinois, Urbana-Champaign.
Abstract
OBJECTIVES: To (1) investigate effects of aerobic walking on motor function, cognition, and quality of life in Parkinson disease (PD), and (2) compare safety, tolerability, and fitness benefits of different forms of exercise intervention: continuous/moderate intensity vs interval/alternating between low and vigorous intensity, and individual/neighborhood vs group/facility setting. METHODS: Initial design was a 6-month, 2 × 2 randomized trial of different exercise regimens in independently ambulatory patients with PD. All arms were required to exercise 3 times per week, 45 minutes per session. RESULTS: Randomization to group/facility setting was not feasible because of logistical factors. Over the first 2 years, we randomized 43 participants to continuous or interval training. Because preliminary analyses suggested higher musculoskeletal adverse events in the interval group and lack of difference between training methods in improving fitness, the next 17 participants were allocated only to continuous training. Eighty-one percent of 60 participants completed the study with a mean attendance of 83.3% (95% confidence interval: 77.5%-89.0%), exercising at 46.8% (44.0%-49.7%) of their heart rate reserve. There were no serious adverse events. Across all completers, we observed improvements in maximum oxygen consumption, gait speed, Unified Parkinson's Disease Rating Scale sections I and III scores (particularly axial functions and rigidity), fatigue, depression, quality of life (e.g., psychological outlook), and flanker task scores (p < 0.05 to p < 0.001). Increase in maximum oxygen consumption correlated with improvements on the flanker task and quality of life (p < 0.05). CONCLUSIONS: Our preliminary study suggests that aerobic walking in a community setting is safe, well tolerated, and improves aerobic fitness, motor function, fatigue, mood, executive control, and quality of life in mild to moderate PD. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that in patients with PD, an aerobic exercise program improves aerobic fitness, motor function, fatigue, mood, and cognition.
OBJECTIVES: To (1) investigate effects of aerobic walking on motor function, cognition, and quality of life in Parkinson disease (PD), and (2) compare safety, tolerability, and fitness benefits of different forms of exercise intervention: continuous/moderate intensity vs interval/alternating between low and vigorous intensity, and individual/neighborhood vs group/facility setting. METHODS: Initial design was a 6-month, 2 × 2 randomized trial of different exercise regimens in independently ambulatory patients with PD. All arms were required to exercise 3 times per week, 45 minutes per session. RESULTS: Randomization to group/facility setting was not feasible because of logistical factors. Over the first 2 years, we randomized 43 participants to continuous or interval training. Because preliminary analyses suggested higher musculoskeletal adverse events in the interval group and lack of difference between training methods in improving fitness, the next 17 participants were allocated only to continuous training. Eighty-one percent of 60 participants completed the study with a mean attendance of 83.3% (95% confidence interval: 77.5%-89.0%), exercising at 46.8% (44.0%-49.7%) of their heart rate reserve. There were no serious adverse events. Across all completers, we observed improvements in maximum oxygen consumption, gait speed, Unified Parkinson's Disease Rating Scale sections I and III scores (particularly axial functions and rigidity), fatigue, depression, quality of life (e.g., psychological outlook), and flanker task scores (p < 0.05 to p < 0.001). Increase in maximum oxygen consumption correlated with improvements on the flanker task and quality of life (p < 0.05). CONCLUSIONS: Our preliminary study suggests that aerobic walking in a community setting is safe, well tolerated, and improves aerobic fitness, motor function, fatigue, mood, executive control, and quality of life in mild to moderate PD. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that in patients with PD, an aerobic exercise program improves aerobic fitness, motor function, fatigue, mood, and cognition.
Authors: Gary J Balady; Ross Arena; Kathy Sietsema; Jonathan Myers; Lola Coke; Gerald F Fletcher; Daniel Forman; Barry Franklin; Marco Guazzi; Martha Gulati; Steven J Keteyian; Carl J Lavie; Richard Macko; Donna Mancini; Richard V Milani Journal: Circulation Date: 2010-06-28 Impact factor: 29.690
Authors: Kelvin L Chou; Melissa M Amick; Jason Brandt; Richard Camicioli; Karen Frei; Darren Gitelman; Jennifer Goldman; John Growdon; Howard I Hurtig; Bonnie Levin; Irene Litvan; Laura Marsh; Tanya Simuni; Alexander I Tröster; Ergun Y Uc Journal: Mov Disord Date: 2010-11-15 Impact factor: 10.338
Authors: Beth E Fisher; Allan D Wu; George J Salem; Jooeun Song; Chien-Ho Janice Lin; Jeanine Yip; Steven Cen; James Gordon; Michael Jakowec; Giselle Petzinger Journal: Arch Phys Med Rehabil Date: 2008-06-13 Impact factor: 3.966
Authors: Giselle M Petzinger; Beth E Fisher; Sarah McEwen; Jeff A Beeler; John P Walsh; Michael W Jakowec Journal: Lancet Neurol Date: 2013-07 Impact factor: 44.182
Authors: G B Neuberger; A N Press; H B Lindsley; R Hinton; P E Cagle; K Carlson; S Scott; J Dahl; B Kramer Journal: Res Nurs Health Date: 1997-06 Impact factor: 2.228
Authors: Stanley J Colcombe; Arthur F Kramer; Kirk I Erickson; Paige Scalf; Edward McAuley; Neal J Cohen; Andrew Webb; Gerry J Jerome; David X Marquez; Steriani Elavsky Journal: Proc Natl Acad Sci U S A Date: 2004-02-20 Impact factor: 11.205
Authors: Laura D Baker; Laura L Frank; Karen Foster-Schubert; Pattie S Green; Charles W Wilkinson; Anne McTiernan; Stephen R Plymate; Mark A Fishel; G Stennis Watson; Brenna A Cholerton; Glen E Duncan; Pankaj D Mehta; Suzanne Craft Journal: Arch Neurol Date: 2010-01
Authors: Ulrik Wisløff; Asbjørn Støylen; Jan P Loennechen; Morten Bruvold; Øivind Rognmo; Per Magnus Haram; Arnt Erik Tjønna; Jan Helgerud; Stig A Slørdahl; Sang Jun Lee; Vibeke Videm; Anja Bye; Godfrey L Smith; Sonia M Najjar; Øyvind Ellingsen; Terje Skjaerpe Journal: Circulation Date: 2007-06-04 Impact factor: 29.690
Authors: Margaret Schenkman; Charity G Moore; Wendy M Kohrt; Deborah A Hall; Anthony Delitto; Cynthia L Comella; Deborah A Josbeno; Cory L Christiansen; Brian D Berman; Benzi M Kluger; Edward L Melanson; Samay Jain; Julie A Robichaud; Cynthia Poon; Daniel M Corcos Journal: JAMA Neurol Date: 2018-02-01 Impact factor: 18.302
Authors: Fabian J David; Julie A Robichaud; Sue E Leurgans; Cynthia Poon; Wendy M Kohrt; Jennifer G Goldman; Cynthia L Comella; David E Vaillancourt; Daniel M Corcos Journal: Mov Disord Date: 2015-07-06 Impact factor: 10.338
Authors: Krystal L Parker; Kuan-Hua Chen; Johnathan R Kingyon; James F Cavanagh; Nandakumar S Narayanan Journal: J Neurophysiol Date: 2015-07-01 Impact factor: 2.714
Authors: Robert D Salazar; Xiaolin Ren; Terry D Ellis; Noor Toraif; Olivier J Barthelemy; Sandy Neargarder; Alice Cronin-Golomb Journal: Neuropsychology Date: 2017-04-17 Impact factor: 3.295